NeuBase Therapeutics, Inc. announced a private placement of 1,366,829 common shares at an issue price of $2.57 per share for gross proceeds of $3,512,750.53 on June 28, 2023. The company also issued unregistered Series A warrants to purchase up to an aggregate of 1,945,526 shares of common stock and unregistered short-term Series B warrants to purchase up to an aggregate of 1,945,526 shares of common stock.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | -3.20% | 0.00% | -48.93% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.93% | 1.39M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |